The Emory Stem Cell Core (ESCC) is one of the newest members of the Emory Integrated Core Facilities (EICF). The ESCC brings a powerful new research platform in support of Emory investigators. This core’s focus and technical expertise will be to derive and characterize human induced pluripotent stem cells (iPSCs) from terminally differentiated somatic cells using non-integrating methods. Additionally, the core will provide training and educational resources to support investigators with interest in human stem cells. IPSCs generated from patients with a genetic defect allows for a unique opportunity to study the mechanisms of disease in an in vitro model. Other applications for these cells include developing a reporter line, drug screening and discovery, and potentially regenerative therapies. The core plans to interface with other members of the Emory Integrated Core Facilities as a pipeline to analyze patient cells that will inform drug discovery and personalized medicine.
The Emory Stem Cell Core (ESCC) is subsidized by the Emory University School of Medicine and is one of the Emory Integrated Core Facilities. Additional support is provided by the National Center for Georgia Clinical & Translational Science Alliance of the National Institutes of Health under Award Number UL1TR002378.